Valence Investments SPV IV LLC - 20 Mar 2023 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Role
10%+ Owner
Signature
Valence Investments SPV IV, LLC, by /s/ Eric Roberts, Manager
Issuer symbol
CALC
Transactions as of
20 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 May 2023, 20:53:54 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CALC Common Stock Award +356,989 356,989 20 Mar 2023 Direct F1
transaction CALC Common Stock Award +66,228 66,228 20 Mar 2023 By Valence Investments SPV V, LLC F2
transaction CALC Common Stock Award +316,109 316,109 20 Mar 2023 By Valence Investments SPV VI, LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CALC Warrant Award +9,935 9,935 20 Mar 2023 Common Stock 9,935 $27.94 By Valence Investments SPV V, LLC F4, F5
transaction CALC Warrant Award +9,935 9,935 20 Mar 2023 Common Stock 9,935 $27.94 By Valence Investments SPV V, LLC F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received in exchange for an aggregate of 12,395,423 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.
F2 Received in exchange for 2,299,564 shares of the common stock of CalciMedica pursuant to the Merger Agreement.
F3 Received in exchange for 10,975,977 shares of the common stock of CalciMedica pursuant to the Merger Agreement.
F4 Immediately exercisable.
F5 Received in exchange for a warrant to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement.